Zoetis receives UK approval for Portela feline OA therapy
The long-acting anti-NGF monoclonal antibody provides pain relief for up to three months with a single injection
See the latest news and media coverage for Zoetis. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global animal health company
zoetis.comLast updated
In short: Zoetis reported strong 2025 earnings but lowered its 2026 outlook due to soft U.S. demand, while expanding its diagnostic and AI portfolio.
The long-acting anti-NGF monoclonal antibody provides pain relief for up to three months with a single injection
The first long-acting anti-NGF monoclonal antibody for cats offers three months of osteoarthritis pain relief with a single injection.
The acquisition adds teleradiology and imaging services to strengthen Zoetis' Global Diagnostics portfolio, advancing toward a comprehensive Virtual Reference Lab.
The vaccine protects chickens against Newcastle and Marek's disease in a single dose.
Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings...
Zoetis Inc. (NYSE:ZTS) Q3 2025 Earnings Call Transcript November 4, 2025 Zoetis Inc. beats earnings expectations. Reported EPS is $1.7, expectations were $1.62. Operator: Good...
On October 03, 2023, UBS maintains a Neutral rating on Zoetis (ZTS). The price target has been...
Nationally Recognized Firm Urges Zoetis Investors to Explore Class Action Representation...
Track Zoetis and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.